Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Cohort Study of Pancreatic Cancer Risk
A Mayo Clinic-led cohort study is investigating the risk of pancreatic cancer in individuals with familial pancreatic cancer. The study is c…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial [NA]
Clinical trial update for the RE-BUILD study evaluating resistance exercise combined with protein supplementation in individuals with pancre…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With Cancer-Related Celiac Pain [Phase 1]
Phase 1 study of simulation-free celiac plexus pain ablation using SBRT for cancer-related celiac pain. The trial is not yet recruiting and …
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy [Phase 1]
A Phase 1, non-randomized study evaluating the safety of adding anakinra to standard chemotherapy in pancreatic cancer; the trial has comple…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors [Phase 1, Phase 2]
Clinical Trial Update on an ongoing Phase 1/2 study of allogeneic NK cells (EBNK-001) with low-dose interleukin-15, with or without pembroli…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
Tasca Therapeutics is testing CP-383 in a Phase 1/2 trial for patients with advanced or metastatic solid tumors, including colorectal cancer…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Endoscopic Management of Biliopancreatic Disease in the Lombardy Pancreas Units
A clinical trial update describing endoscopic management of biliopancreatic disease in Lombardy pancreas units; the study is not yet recruit…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Exploratory Clinical Study of Claudin18.2-Targeted Activated DC and CAR-T Therapy in Advanced Pancreatic Cancer. [EARLY_Phase 1]
An early-phase exploratory clinical study is evaluating Claudin18.2-targeted Activated Dendritic Cells and Claudin18.2-targeted CAR-T therap…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Endoscopic Ultrasound Radiofrequency Ablation, Database Repository
Ongoing clinical trial update from Indiana University on Endoscopic Ultrasound Radiofrequency Ablation for pancreatic cancer; enrollment is …
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Comparison of Prognosis Between Open Pancreatic Surgery With Vein Resection and Reconstruction Versus Minimally Invasive Pancreatic Surgery With Vein Resection and Reconstruction for Pancreatic Cancer
This completed clinical trial compares prognosis following open pancreatic surgery with vein resection and reconstruction to minimally invas…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma [Phase 1, Phase 2]
The Phase 1/2 trial evaluating CMP-001 and INCAGN01949 for stage IV pancreatic cancer and other non-melanoma solid tumors was terminated; re…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial of MRG007 (ARR-217) in patients with advanced solid tumors is recruiting, evaluating safety and initial efficacy signals in …
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma [Phase 1]
Phase 1 clinical trial update for TNhYP218 anti-mesothelin CAR T cells in mesothelin-expressing solid tumors, including mesothelioma; recrui…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP) [NA]
A clinical trial update describing the Italian Tumor Chemogenomic Profiler (IT-TCP), an integrative multi-omics and functional platform to d…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: IBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial is evaluating IBI343 in combination with chemotherapy as neoadjuvant therapy for borderline resectable pancreatic c…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: The Effect of Celiac Axis Stenosis on Morbidity After Pancreatoduodenectomy - A Prospective Study
A prospective clinical trial update examining whether celiac axis stenosis influences morbidity after pancreaticoduodenectomy, currently act…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations [Phase 2]
A Phase II nationwide, fully decentralized telemedicine study of pemigatinib for adults with FGFR-altered advanced or metastatic pancreatic …
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Niraparib as First Line Therapy With Metastatic Homologous Repair-deficient Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating niraparib as first-line therapy for metastatic homologous recombination-deficient pancreatic cancer has been term…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Combined Chemotherapy And Ablative Radiotherapy (SBRT) As First-Line Treatment In Locally Advanced Inoperable Pancreatic Cancer (SBRT-PANC) [NA]
Clinical trial NCT07407231 is evaluating combined chemotherapy and ablative radiotherapy (SBRT) as first-line treatment for locally advanced…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Assessment of the Prognosis of Pancreatic Cancer Patients Using 3D MRE
This clinical trial entry indicates a study evaluating whether 3D magnetic resonance elastography can predict prognosis in pancreatic cancer…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors [Phase 1, Phase 2]
Phase 1/2 dose-finding study evaluating safety, pharmacokinetics, and dose optimization of a new therapy in advanced refractory solid tumors…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation [Phase 1]
This clinical trial update states that CLSP-1025 is being evaluated in a Phase 1 study for adults with solid tumors harboring the p53 R175H …
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: XH001 Combination With Immunocheckpoint Inhibitor and Chemotherapy for Patients With Resected Pancreatic Cancer [NA]
A clinical trial update states that XH001 is being studied in combination with an immunocheckpoint inhibitor and chemotherapy for patients w…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
This ClinicalTrials.gov entry describes a study by A2 Biotherapeutics evaluating HLA LOH analysis and apheresis for CAR-T cell manufacturing…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: FOLFIRINOX Versus OncoSil™ in Addition to FOLFIRINOX in Patients With Locally Advanced Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial comparing FOLFIRINOX with and without OncoSil in locally advanced pancreatic cancer; the study is currently active but not rec…